MSME (Udyam registered) Ministry of MSME
- Category
- Small (2023-24)
- Udyam number
- UDYAM-HP-11-0004239
Dagon Pharmaceuticals Private Limited - pharma in Vadodara, Gujarat, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹24.08 Cr
▲ 3% YoY
Net profit · FY 2025
₹1.29 Cr
Net margin 5.3%
EBITDA · FY 2025
₹2.65 Cr
EBITDA margin 11%
Authorised capital
₹2.5 Cr
Registered with MCA
Paid-up capital
₹2.25 Cr
Issued & subscribed
Open charges
₹17.06 Cr
Satisfied ₹4.45 Cr
Company age
33 yrs
Est. 1993
Directors on board
3
As per MCA filings
About Dagon Pharmaceuticals Private Limited
Data last updated:
Dagon Pharmaceuticals Private Limited is a private limited company based in Vadodara, Gujarat, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 02 April 1993 and has been in existence for over 33 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24231GJ1993PTC019247. Its GSTIN is 24AAACD9884A1ZR (Gujarat). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹2.5 Cr and a paid-up capital of ₹2.25 Cr. It is led by directors including Gautam Ishwarbhai Bhut (Whole-Time Director) and Kishorbhai Mahidas Bhut (Whole-Time Director).
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 211 Silver Coin Shrenik Park Char Rasta Productivity Road Akota, Vadodara, Gujarat, India – 390020.
As per the financials filed for FY 2025, the company reported a revenue of ₹24.08 Cr, a growth of 3% compared to the previous year. For the same year it recorded a net profit of ₹1.29 Cr (net margin 5.3%) and EBITDA of ₹2.65 Cr (EBITDA margin 11%). Revenue has grown at a compounded annual rate (CAGR) of 12% over three years and 2% over five years.
The company is associated with 1 brand: Dagon Pharmaceuticals. As per MCA filings, the company has open charges of ₹17.06 Cr and satisfied charges of ₹4.45 Cr on record. Court records list 2 cases involving the company, including 2 filed against it; 1 case is pending.
Dagon Pharmaceuticals Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-HP-11-0004239). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website dagonpharma.com.
Company details
CIN U24231GJ1993PTC019247
Registration Number 019247
Incorporation Date 02 April 1993
ROC Ahmedabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-HP-11-0004239
Key People
Gautam Ishwarbhai Bhut Whole-Time Director Kishorbhai Mahidas Bhut Whole-Time Director Bhupatbhai Mahidasbhai Bhut Director Recognitions & Rankings of Dagon Pharmaceuticals
Contact details
Dagon Pharmaceuticals Private Limited's registered office is in Vadodara, Gujarat. Its website is dagonpharma.com. Its e-mail address is in the company report.
- Email
- Website
- Registered Address211 Silver Coin Shrenik Park Char Rasta Productivity Road Akota, Vadodara, Gujarat, India – 390020
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Dagon Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Dagon Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Dagon Pharmaceuticals operates one associated brand: Dagon Pharmaceuticals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufacturing of pharmaceutical products including tablets, capsules, oral liquids, powders, injectables, and nutraceuticals. | dagonpharma.com |
Business activity
The main business activity of Dagon Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Dagon Pharmaceuticals Private Limited, buy the company report.
Financials of Dagon Pharmaceuticals Private Limited
FY 2025 filings availableDagon Pharmaceuticals Private Limited reported revenue of ₹24.08 Cr (up 3% YoY) for FY 2025.
Revenue · FY 2025
₹24.08 Cr ▲ 3%
Net profit · FY 2025
₹1.29 Cr margin 5.3%
EBITDA · FY 2025
₹2.65 Cr margin 11%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 3%
3 years · compounded
▼ 12%
5 years · compounded
▲ 2%
EBITDA CAGR growth
1 year
▲ 17%
3 years · compounded
▲ 1%
5 years · compounded
▲ 10%
Revenue has grown at a compounded annual rate (CAGR) of 2% over five years, including 3% growth in the latest year. EBITDA rose 17% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.65 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.29 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 11% | ||||
| Net Profit Margin | 5.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Dagon Pharmaceuticals Private Limited, buy the company report.
Board of directors of Dagon Pharmaceuticals Private Limited
Dagon Pharmaceuticals has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Bhupatbhai Mahidasbhai Bhut Also directs: Dagon Healthcare Private Limited | Director | 02 Feb 2005 | 21 Years 9 Months | Current |
| Gautam Ishwarbhai Bhut | Whole-Time Director | 24 Mar 2001 | 25 Years 7 Months | Current |
| Kishorbhai Mahidas Bhut | Whole-Time Director | 02 Apr 1993 | 33 Years 7 Months | Current |
Peer comparison
Dagon Pharmaceuticals Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Ultra Drugs Formulations Private Limited | ₹24.17 Cr (FY 2024) | 198.0% | Baddi, Himachal Pradesh, India | |||
| Alchemy Medicine Private Limited | ₹24.15 Cr (FY 2025) | 28.0% | New Delhi, Delhi, India | |||
| Dagon Pharmaceuticals Private Limitedthis company | ₹24.08 Cr (FY 2025) | ₹1.29 Cr | 5.3% | 3.0% | Vadodara, Gujarat, India | |
| Lyra Laboratories Private Limited | ₹24.06 Cr (FY 2025) | 1.0% | Buranwala, Himachal Pradesh, India | |||
| Cosmas Pharmacls Limited | ₹23.95 Cr (FY 2025) | 1.0% | Ludhiana, Punjab, India | |||
| Decipher Labs Limited | ₹23.93 Cr (FY 2025) | -34.0% | Hyderabad, Telangana, India | |||
| Suru Chemicals and Pharmaceuticals Private Limited | ₹23.88 Cr (FY 2025) | -8.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Dagon Pharmaceuticals Private Limited, buy the company report.
Auditor
Dagon Pharmaceuticals Private Limited is audited by Pathak Anjaria & Co for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Pathak Anjaria & Co | FY 2024 | 107782W |
Shareholding
The shareholding of Dagon Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Dagon Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹17.06 Cr
Satisfied charges
₹4.45 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 26 Jul 2024 | 100955452 | Sidbi | ₹93 Lakh | Open | |
| 26 Jul 2024 | 100955450 | Sidbi | ₹1.12 Cr | Open | |
| 02 Mar 2022 | 100544669 | Sidbi | ₹1.23 Cr | Open | |
| 23 Jun 2021 | 100463503 | Sidbi | ₹98.97 Lakh | Open | |
| 11 Jun 2020 | 100339800 | Sidbi | ₹50 Lakh | Open |
To see the full charge records of Dagon Pharmaceuticals Private Limited, buy the company report.
Total charge records: 9 View all charges
Legal cases
Dagon Pharmaceuticals Private Limited has 2 court cases on record: 2 filed against it. 1 case is pending and 1 is disposed.
Total cases
2
Filed against the company
2
Pending
1
Disposed
1
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 1 | 0 |
| High courts | 1 | 1 | 1 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court | Court case (COMIP) | Filed against the company by Aristo Pharmaceuticals Private Limited | Pending |
| District court, Solan, Himachal Pradesh | Court case (Suit For Recovery) | Filed against the company by Ms Morpen Laboratories Ltd. | Disposed |
To see the full case history of Dagon Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Dagon Pharmaceuticals Private Limited has 5 MSME Form 1 returns on record between 2019 and 2023, listing 223 overdue payments to 114 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 114)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Accurmax Solutions Private Limited | |||
| an individual supplier | |||
| an individual supplier | |||
| LCGC Bioanalytic Solutions LLP | |||
| Shree Nath Chemicals |
To see the full MSME payment records of Dagon Pharmaceuticals Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
GST
Dagon Pharmaceuticals has 2 GST registrations: 2 active.
Total GSTINs
2
Active
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAACD9884A1ZR | Gujarat | Active | 01 Jul 2017 |
| 02AAACD9884A1ZX | Himachal Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Dagon Pharmaceuticals Private Limited, buy the company report.
Recent activity
Dagon Pharmaceuticals Private Limited has 5 board changes on record since 1993: 3 appointments and 2 cessations. The latest: Gautam Ishwarbhai Bhut ceased to be Director on 30 Sep 2019.
AGM
Dagon Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Dagon Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad.
Charges
A charge with Sidbi amounted to Rs. 0.93 Cr with Charge ID 100955452 was registered on 26 Jul 2024.
Charges
A charge with Sidbi amounted to Rs. 1.12 Cr with Charge ID 100955450 was registered on 26 Jul 2024.
Charges
A charge with Sidbi amounted to Rs. 1.23 Cr with Charge ID 100544669 was registered on 02 Mar 2022.
Charges
A charge with Sidbi amounted to Rs. 0.99 Cr with Charge ID 100463503 was registered on 23 Jun 2021.
Charges
A charge with Sidbi amounted to Rs. 0.50 Cr with Charge ID 100339800 was registered on 11 Jun 2020.
Ceased
Gautam Ishwarbhai Bhut ceased to be Director.
Ceased
Kishorbhai Mahidas Bhut ceased to be Director.
Charges
A charge with Canara Bank of Rs. 12.00 Cr registered on 02 Feb 2007 with Charge ID 10042460 was modified on 26 Feb 2014.
Charges
A charge with Dyputy Director Of Industries amounted to Rs. 0.30 Cr with Charge ID 10164713 was registered on 22 Jun 2009.
Charges
A charge registered on 14 Mar 1996 via Charge ID 90100462 with State Bank Of India was fully satisfied on 15 Mar 2007.
9 earlier events are in the company report.
Frequently asked questions
Dagon Pharmaceuticals is an active private limited company based in Vadodara, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 02 April 1993 (33+ years old) and is registered under CIN U24231GJ1993PTC019247.
Dagon Pharmaceuticals has 3 current directors:
- Gautam Ishwarbhai Bhut - Whole-Time Director
- Kishorbhai Mahidas Bhut - Whole-Time Director
- Bhupatbhai Mahidasbhai Bhut - Director
The latest financial statements of Dagon Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Dagon Pharmaceuticals is 24AAACD9884A1ZR, registered in Gujarat. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 02AAACD9884A1ZX (Himachal Pradesh).
The CIN (Corporate Identification Number) of Dagon Pharmaceuticals is U24231GJ1993PTC019247. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Dagon Pharmaceuticals has 2 court cases on record: 2 filed against it. 1 is pending. Most are in the district courts.
Dagon Pharmaceuticals was incorporated on 02 April 1993, making it 33+ years old. It is registered with the Registrar of Companies, Ahmedabad.
The peers of Dagon Pharmaceuticals by revenue are Ultra Drugs Formulations Private Limited, Alchemy Medicine Private Limited, Lyra Laboratories Private Limited, Cosmas Pharmacls Limited, Decipher Labs Limited and 1 more, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Gautam Ishwarbhai Bhut ceased to be Director on 30 Sep 2019. Kishorbhai Mahidas Bhut ceased to be Director on 30 Sep 2019. Bhupatbhai Mahidasbhai Bhut was appointed as Director on 02 Feb 2005. Dagon Pharmaceuticals has 5 board changes on record in total.
Yes, Dagon Pharmaceuticals is registered as a small enterprise under Udyam registration (number: UDYAM-HP-11-0004239).
Dagon Pharmaceuticals has 5 MSME Form 1 returns on record between 2019 and 2023, listing 223 overdue payments to 114 micro and small suppliers. The latest return was filed on 29 Dec 2023.
Dagon Pharmaceuticals can be reached through the website dagonpharma.com. Its registered office is in Vadodara, Gujarat, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages